suprachoroidal - Shore News Network

New Survey Shows Retina Specialists Believe Suprachoroidal Administration is an Option for Patients With Macular Edema Associated With Noninfectious Uveitis

May 12, 2022

Survey Reinforces Need for Innovative Therapies, Including Options Administered Through Suprachoroidal Space VAUGHAN, ON, May 12, 2022 — Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch …

Bausch + Lomb and Clearside Biomedical Announce the U.S. Commercial Launch of XIPERE® (Triamcinolone Acetonide Injectable Suspension) For Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis

March 28, 2022

“XIPERE® is the first and only therapy available in the United States that utilizes the suprachoroidal space to treat patients who struggle with macular edema …